The central and peripheral influences of opioids on gastrointestinal propulsion
- PMID: 3890704
- DOI: 10.1146/annurev.pa.25.040185.001341
The central and peripheral influences of opioids on gastrointestinal propulsion
Similar articles
-
Central versus peripheral effects of muscarinic antagonists: the limitations of quaternary ammonium derivatives.Psychopharmacology (Berl). 1992;108(1-2):241-3. doi: 10.1007/BF02245315. Psychopharmacology (Berl). 1992. PMID: 1410143 Review. No abstract available.
-
Is in vivo dissociation between the antipropulsive and antidiarrheal properties of opioids in rats related to gut selectivity?Arch Int Pharmacodyn Ther. 1989 Mar-Apr;298:220-9. Arch Int Pharmacodyn Ther. 1989. PMID: 2569297
-
Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats.J Pharmacol Exp Ther. 1986 Jan;236(1):8-13. J Pharmacol Exp Ther. 1986. PMID: 3941402
-
Effects and mechanisms of electroacupuncture on glucagon-induced small intestinal hypomotility in dogs.Neurogastroenterol Motil. 2010 Nov;22(11):1217-23, e318. doi: 10.1111/j.1365-2982.2010.01565.x. Epub 2010 Aug 19. Neurogastroenterol Motil. 2010. PMID: 20723072
-
Pharmacology of antidiarrheal drugs.Annu Rev Pharmacol Toxicol. 1983;23:279-301. doi: 10.1146/annurev.pa.23.040183.001431. Annu Rev Pharmacol Toxicol. 1983. PMID: 6307123 Review. No abstract available.
Cited by
-
Rational pharmacotherapy of gastrointestinal motility disorders.Eur J Pediatr. 1989 Apr;148(6):489-95. doi: 10.1007/BF00441540. Eur J Pediatr. 1989. PMID: 2663504 Review.
-
Proceedings of the British Pharmacological Society. Clinical Pharmacology Section. 14-16 April 1993. Abstracts.Br J Clin Pharmacol. 1993 Aug;36(2):139P-182P. doi: 10.1111/j.1365-2125.1993.tb04214.x. Br J Clin Pharmacol. 1993. PMID: 8398587 Free PMC article. No abstract available.
-
Postoperative ileus: progress towards effective management.Drugs. 2002;62(18):2603-15. doi: 10.2165/00003495-200262180-00004. Drugs. 2002. PMID: 12466000 Review.
-
Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.J Pharm Pract. 2018 Dec;31(6):658-669. doi: 10.1177/0897190017732263. Epub 2017 Sep 25. J Pharm Pract. 2018. PMID: 28946783 Free PMC article. Review.
-
Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity.Br J Pharmacol. 2015 Sep;172(17):4419-29. doi: 10.1111/bph.13224. Epub 2015 Jul 30. Br J Pharmacol. 2015. PMID: 26075589 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources